Literature DB >> 26478666

Immune and non-immune responses to hepatitis C virus infection.

Jiaren Sun1, Ricardo Rajsbaum1, MinKyung Yi1.   

Abstract

The host innate and adaptive immune systems are involved in nearly every step of hepatitis C virus (HCV) infection. In patients, the outcome is determined by a series of complex host-virus interactions, whether it is a natural infection or results from clinical intervention. Strong and persistent CD8(+) and CD4(+) T-cell responses are critical in HCV clearance, as well as cytokine-induced factors that can directly inhibit virus replication. Newly available direct-acting antivirals (DAAs) are very effective in viral clearance in patients. DAA treatment may further result in the down-regulation of programmed death-1, leading to rapid restoration of HCV-specific CD8(+) T cell functions. In this review, we focus on recent studies that address the host responses critical for viral clearance and disease resolution. Additional discussion is devoted to the prophylactic vaccine development as well as to current efforts aimed at understanding the host innate responses against HCV infection. Current theories on how the ubiquitin system and interferon-stimulated genes may affect HCV replication are also discussed.

Entities:  

Keywords:  Direct-acting antiviral; Hepatitis; Hepatitis C virus; Innate immune response; T cell

Mesh:

Substances:

Year:  2015        PMID: 26478666      PMCID: PMC4600576          DOI: 10.3748/wjg.v21.i38.10739

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  96 in total

Review 1.  Regulation of hepatic innate immunity by hepatitis C virus.

Authors:  Stacy M Horner; Michael Gale
Journal:  Nat Med       Date:  2013-07       Impact factor: 53.440

2.  Phase 1b study of pegylated interferon lambda 1 with or without ribavirin in patients with chronic genotype 1 hepatitis C virus infection.

Authors:  Andrew J Muir; Mitchell L Shiffman; Atif Zaman; Boris Yoffe; Andrew de la Torre; Steven Flamm; Stuart C Gordon; Paul Marotta; John M Vierling; Juan Carlos Lopez-Talavera; Kelly Byrnes-Blake; David Fontana; Jeremy Freeman; Todd Gray; Diana Hausman; Naomi N Hunder; Eric Lawitz
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

3.  Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation.

Authors:  Jin Ye; Chunfu Wang; Rhea Sumpter; Michael S Brown; Joseph L Goldstein; Michael Gale
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-10       Impact factor: 11.205

Review 4.  Animal models for hepatitis C.

Authors:  Eva Billerbeck; Ype de Jong; Marcus Dorner; Cynthia de la Fuente; Alexander Ploss
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

Review 5.  Hepatitis C drugs: the end of the pegylated interferon era and the emergence of all-oral interferon-free antiviral regimens: a concise review.

Authors:  Alan Hoi Lun Yau; Eric M Yoshida
Journal:  Can J Gastroenterol Hepatol       Date:  2014-09

Review 6.  Viral evasion mechanisms of early antiviral responses involving regulation of ubiquitin pathways.

Authors:  Ricardo Rajsbaum; Adolfo García-Sastre
Journal:  Trends Microbiol       Date:  2013-07-11       Impact factor: 17.079

Review 7.  Interferon-stimulated genes and their antiviral effector functions.

Authors:  John W Schoggins; Charles M Rice
Journal:  Curr Opin Virol       Date:  2011-12       Impact factor: 7.090

8.  A distinct role of Riplet-mediated K63-Linked polyubiquitination of the RIG-I repressor domain in human antiviral innate immune responses.

Authors:  Hiroyuki Oshiumi; Moeko Miyashita; Misako Matsumoto; Tsukasa Seya
Journal:  PLoS Pathog       Date:  2013-08-08       Impact factor: 6.823

9.  The roles of two IkappaB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection.

Authors:  Hiroaki Hemmi; Osamu Takeuchi; Shintaro Sato; Masahiro Yamamoto; Tsuneyasu Kaisho; Hideki Sanjo; Taro Kawai; Katsuaki Hoshino; Kiyoshi Takeda; Shizuo Akira
Journal:  J Exp Med       Date:  2004-06-21       Impact factor: 14.307

Review 10.  Regulation of the innate immune system by ubiquitin and ubiquitin-like modifiers.

Authors:  Diede Oudshoorn; Gijs A Versteeg; Marjolein Kikkert
Journal:  Cytokine Growth Factor Rev       Date:  2012-09-08       Impact factor: 7.638

View more
  10 in total

1.  Different effects of the immunostimulatory drug Stimforte on infections of hepatitis C virus and herpes simplex virus type 1.

Authors:  D G Maldov; V L Andronova; S S Grigorian; E I Isaeva; P G Deryabin; D V Mishin; A A Balakina; A V Ilyichev; A A Terentyev; G A Galegov
Journal:  Dokl Biol Sci       Date:  2018-01-04

2.  Unique Type I Interferon, Expansion/Survival Cytokines, and JAK/STAT Gene Signatures of Multifunctional Herpes Simplex Virus-Specific Effector Memory CD8+ TEM Cells Are Associated with Asymptomatic Herpes in Humans.

Authors:  Hawa Vahed; Anshu Agrawal; Ruchi Srivastava; Swayam Prakash; Pierre-Gregoire A Coulon; Soumyabrata Roy; Lbachir BenMohamed
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

3.  HCV core protein inhibits polarization and activity of both M1 and M2 macrophages through the TLR2 signaling pathway.

Authors:  Qianqian Zhang; Yang Wang; Naicui Zhai; Hongxiao Song; Haijun Li; Yang Yang; Tianyang Li; Xiaolin Guo; Baorong Chi; Junqi Niu; Ian Nicholas Crispe; Lishan Su; Zhengkun Tu
Journal:  Sci Rep       Date:  2016-10-27       Impact factor: 4.379

4.  Eight Weeks of Ledipasvir/Sofosbuvir in Kidney Transplant Recipients With Hepatitis C Genotype 1 Infection.

Authors:  Jennifer S Husson; Bharath Ravichandran; Srijana Jonchhe; Shyamasundaran Kottilil; Eleanor Wilson
Journal:  Transplant Direct       Date:  2017-11-03

Review 5.  Long Non-coding RNAs in Hepatitis C Virus-Infected Cells.

Authors:  Marina Barriocanal; Puri Fortes
Journal:  Front Microbiol       Date:  2017-09-28       Impact factor: 5.640

6.  Cellular Gene Expression during Hepatitis C Virus Replication as Revealed by Ribosome Profiling.

Authors:  Gesche K Gerresheim; Jochen Bathke; Audrey M Michel; Dmitri E Andreev; Lyudmila A Shalamova; Oliver Rossbach; Pan Hu; Dieter Glebe; Markus Fricke; Manja Marz; Alexander Goesmann; Stephen J Kiniry; Pavel V Baranov; Ivan N Shatsky; Michael Niepmann
Journal:  Int J Mol Sci       Date:  2019-03-15       Impact factor: 5.923

7.  Lnc-ITM2C-1 and GPR55 Are Proviral Host Factors for Hepatitis C Virus.

Authors:  Pan Hu; Jochen Wilhelm; Gesche K Gerresheim; Lyudmila A Shalamova; Michael Niepmann
Journal:  Viruses       Date:  2019-06-13       Impact factor: 5.048

8.  Hepatitis C Virus Clearance by Direct-acting Antiviral Results in Rapid Resolution of Hepatocytic Injury as Indicated by Both Alanine Aminotransferase and Aspartate Aminotransferase Normalization.

Authors:  Tung Huynh; Johnathan Zhang; Ke-Qin Hu
Journal:  J Clin Transl Hepatol       Date:  2018-09-19

Review 9.  Hepatitis C Virus Translation Regulation.

Authors:  Michael Niepmann; Gesche K Gerresheim
Journal:  Int J Mol Sci       Date:  2020-03-27       Impact factor: 5.923

Review 10.  Hepatitis C Virus Downregulates Core Subunits of Oxidative Phosphorylation, Reminiscent of the Warburg Effect in Cancer Cells.

Authors:  Gesche K Gerresheim; Elke Roeb; Audrey M Michel; Michael Niepmann
Journal:  Cells       Date:  2019-11-08       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.